Canopus BioPharma Incorporated (CBIA)

Market Cap	4.55K
Revenue	n/a
Net Income	n/a
Shares Out	4.55B
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,245,900
Average Volume	n/a
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	4.27
RSI	21.12
Earnings Date	n/a

About Canopus BioPharma

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.

• Industry: Advertising Agencies
• Sector: Communication Services
• Founded: 1996
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: CBIA